Proposal for a diagnostic approach to long COVID
Main Article Content
Keywords
Reagent Kits, Diagnosis, Post-Acute COVID-19 Syndrome
Abstract
The objective of this communication is to provide a proposal for a diagnostic approach to persistent COVID based on the various current etiopathogenic theories and to serve as a guide on how to start the diagnostic process in a patient affected by this syndrome according to the prevailing symptomatology and the basic studies and of extension that can be requested and even assisted by commercial kits that would help a better diagnosis.
References
World Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition. Geneva, Switzerland: WHO; 2022. Disponible en: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.
Del Carpio-Orantes L, Aguilar-Silva A. (2023). [Commentary] Long COVID, linking etiopathogenic theories. Qeios. doi: 10.32388/A7TYBN.
Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;8:101019. doi: 10.1016/j.eclinm.2021.101019.
Nunn AVW, Guy GW, Brysch W, et al. Understanding Long COVID; Mitochondrial Health and Adaptation-Old Pathways, New Problems. Biomedicines. 2022;10(12):3113. doi: 10.3390/biomedicines10123113.
Giannos P, Prokopidis K. Gut dysbiosis and long COVID-19: Feeling gutted. J Med Virol. 2022;94(7):2917-2918. doi: 10.1002/jmv.27684.
Chang R, Yen-Ting Chen T, Wang SI, et al. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023;56:101783. doi: 10.1016/j.eclinm.2022.101783.
Chequp. Long-Covid Test. London: Chequp: 2023. Disponible en: https://chequp.com/products/am-i-suffering-the-after-effects-of-covid
Patterson BK, Guevara-Coto J, Yogendra R, et al. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front Immunol. 2021;12:700782. doi: 10.3389/fimmu.2021.700782.
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.